Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Common Equity (2020 - 2025)

Stemtech's Common Equity history spans 6 years, with the latest figure at -$6.5 million for Q3 2025.

  • For Q3 2025, Common Equity changed N/A year-over-year to -$6.5 million; the TTM value through Sep 2025 reached -$6.5 million, changed N/A, while the annual FY2024 figure was -$5.2 million, 88.1% down from the prior year.
  • Common Equity for Q3 2025 was -$6.5 million at Stemtech, down from -$6.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $896097.0 in Q1 2021 and bottomed at -$28.8 million in Q2 2022.
  • The 5-year median for Common Equity is -$4.4 million (2021), against an average of -$5.2 million.
  • The largest annual shift saw Common Equity tumbled 11505.16% in 2022 before it skyrocketed 87.17% in 2023.
  • A 5-year view of Common Equity shows it stood at -$4.0 million in 2021, then rose by 20.81% to -$3.2 million in 2022, then rose by 12.39% to -$2.8 million in 2023, then tumbled by 88.1% to -$5.2 million in 2024, then fell by 25.24% to -$6.5 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Common Equity are -$6.5 million (Q3 2025), -$6.5 million (Q2 2025), and -$5.7 million (Q1 2025).